India's Pharmaceutical Exports

Country Profile

Solomon Islands

Solomon Islands is a developing market for Indian pharmaceuticals — $1.50M in FY 2025–26, with 4.2× growth over the past decade. Medicines accounts for 89% of shipments, with vaccines contributing $104K. The compound annual growth rate since FY2016 stands at 15.5%.

🇸🇧 $1.50M · 4.2× growth since FY2016 · 15.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$1.50M
Exports FY2025–26 DGCIS
4.2×
Growth FY2016→2026
15.5%
CAGR FY2016→2026
89%
Medicines Share
4
Product Categories Supplied
Solomon Islands is a developing market for Indian pharmaceuticals — $1.50M in FY 2025–26, with 4.2× growth over the past decade. Medicines accounts for 89% of shipments, with vaccines contributing $104K. The compound annual growth rate since FY2016 stands at 15.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $1.34M (89.2%) Vaccines $104K (6.9%) Surgical & Hospital Supplies $52K (3.5%) Traditional & Herbal $6K (0.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Solomon Islands in the RBI overseas direct investment dataset (2011–2026).